Co‐production of Tet(X) and MCR‐1, two resistance enzymes by a single plasmid
Open Access
- 8 February 2021
- journal article
- research article
- Published by Wiley in Environmental Microbiology
- Vol. 23 (12), 7445-7464
- https://doi.org/10.1111/1462-2920.15425
Abstract
Tigecycline and colistin are few of ‘last‐resort’ antibiotic defences used in anti‐infection therapies against carbapenem‐resistant bacterial pathogens. The successive emergence of plasmid‐borne tet(X) tigecycline resistance mechanism and mobile colistin resistance (mcr) determinant, renders them clinically useless. Here, we report that co‐carriage of tet(X6) and mcr‐1 gives co‐resistance to both classes of antibiotics by a single plasmid in Escherichia coli. Tet(X6), the new tigecycline resistance enzyme is functionally defined. Both Tet(X6) and MCR‐1 robustly interfere accumulation of antibiotic‐induced reactive oxygen species (ROS). Unlike that mcr‐1 exerts fitness cost in E. coli, tet(X6) does not. In the tet(X6)‐positive strain that co‐harbors mcr‐1, tigecycline resistance is independently of colistin resistance caused by MCR‐1‐mediated lipid A remodelling, and vice versa. In general consistency with that of MCR‐1, Tet(X6) leads to the failure of tigecycline treatment in the infection model of G. mellonella. Taken together, the co‐production of Tet(X) and MCR‐1 appears as a major clinic/public health concern.Funding Information
- National Natural Science Foundation of China (31830001, 81772142)
This publication has 59 references indexed in Scilit:
- Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)Nature Communications, 2013
- Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS productionNature Biotechnology, 2013
- Small changes in enzyme function can lead to surprisingly large fitness effects during adaptive evolution of antibiotic resistanceProceedings of the National Academy of Sciences of the United States of America, 2012
- Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenaseFEBS Letters, 2011
- Easyfig: a genome comparison visualizerBioinformatics, 2011
- Tigecycline: A glycylcycline antimicrobial agentClinical Therapeutics, 2006
- Tigecycline: A New Glycylcycline for Treatment of Serious InfectionsClinical Infectious Diseases, 2005
- Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetXBiochemistry, 2005
- TetX Is a Flavin-dependent Monooxygenase Conferring Resistance to Tetracycline AntibioticsOnline Journal of Public Health Informatics, 2004
- Expression in Escherichia coli of cryptic tetracycline resistance genes from Bacteroides R plasmidsPlasmid, 1984